Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Albuminuria Lowering Response to Dapagliflozin in a Decentralized Clinical Trial in Patients With Type 2 Diabetes Mellitus and Elevated Albuminuria

NCT06374043 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06374043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06374043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Albuminuria Lowering Response to Dapagliflozin in a Decentralized Clinical Trial in Patients With Type 2 Diabetes Mellitus and Elevated Albuminuria
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Completed
Start date
May 11, 2021
Completion date
September 13, 2022
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, chronic kidney disease due to type 2 diabetes mellitus, chronic kidney diseases, ckd, diabetes, diabetes complications, diabetes mellitus, diabetes mellitus type 2 with proteinuria, diabetes mellitus, type 2, proteinuria